Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2025 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Blood Test Uncovers Undiagnosed Diabetes in Hospital Patients With High Blood Sugar

May 23, 2016 By American Osteopathic Association

A retrospective review of medical records found the HbA1C test, commonly used to diagnose and manage diabetes, can effectively detect hidden disease among hospital patients with hyperglycemia, commonly known as high blood sugar.

Hyperglycemia is a frequent finding that can be related to physiologic stress, illness and medications, including steroids and vasopressors. Researchers from Touro University California and Ohio University Heritage College of Osteopathic Medicine reviewed the medical records of 348 patients with hyperglycemia inpatients discovered at admission in a rural community teaching hospital in the Midwest. Of those patients, 50 had no known history of diabetes and 31 of them were given an HbA1C test, which measures the average blood glucose level over the previous eight to 12 weeks.

Researchers from Touro University California and Ohio University Heritage College of Osteopathic Medicine reviewed the medical records of 348 patients with hyperglycemia inpatients discovered at admission in a rural community teaching hospital in the Midwest. Of those patients, 50 had no known history of diabetes and 31 of them were given an HbA1C test, which measures the average blood glucose level over the previous eight to 12 weeks. Among those tested, 77 percent had results consistent with diagnoses of diabetes (58 percent) or prediabetes (19 percent). Ultimately, more than half (55 percent) of patients with no previous history of diabetes received a discharge diagnosis that included diabetes. (Credit: Journal of the American Osteopathic Association)

Among those tested, 77 percent had results consistent with diagnoses of diabetes (58 percent) or prediabetes (19 percent). Ultimately, more than half (55 percent) of patients with no previous history of diabetes received a discharge diagnosis that included diabetes.

“In the hospital, we often find hyperglycemia when we’re treating other illnesses, like sepsis or a heart attack. This study found that patients with no known history of diabetes whose HbA1C level was measured were five times more likely to leave the hospital with a diagnosis of new-onset diabetes,” said Dr. Shubrook.

“That shows us we are missing opportunities to detect diabetes and initiate treatment for those patients to help manage that disease, which can reduce their long-term cost of care and disease burden,” Dr. Shubrook added. “From the osteopathic perspective of early detection equals better outcomes, it’s easy to make a case for hospital protocols to trigger an HbA1C test when hyperglycemia is detected to distinguish between transient hyperglycemia and chronic disease.”

Approximately one in five health care dollars is spent on diabetes care, according to the American Diabetes Association, with the largest percentage of that cost related to inpatient care. Previous studies found that patients who receive a diabetes diagnosis and receive inpatient education have a lower all-cause 30-day hospital readmission rate.

Open access to the full review is available until August.

Related Articles Read More >

A photo of Kolaleh Eskandanian.
Cleared for every child, covered for none, priced for the parents who can pay
A screenshot of the UpDoc app.
What’s UpDoc? The SaMD developer says it’s the first FDA-cleared clinical AI platform
A photo of Dexcom CEO Jake Leach.
Dexcom’s latest executive pay disclosure covers new CEO’s big year
Dukane welding tech supports wearable diabetes device
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2026 Arrowfly, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2025 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe